The Atinary Lab will demonstrate cutting-edge AI and self-driving lab technology in collaboration with Takeda Pharmaceuticals.
MENLO PARK, California, and LAUSANNE, Switzerland – November 7, 2024 – Atinary Technologies is excited to announce an expanded collaboration with Takeda Pharmaceuticals, the largest pharmaceutical company in Japan. The launch of the Atinary Lab, the Self-driving Laboratory™, is a groundbreaking leap toward reshaping the future of R&D with AI-driven, automated workflows in drug discovery and advanced chemistry. Atinary Lab will bring to life the unparalleled potential of SDLabs™, Atinary’s no-code AI platform, alongside cutting-edge autonomous technology. This project will contribute to setting new standards for tackling complex challenges in life sciences and beyond. The Atinary Lab will be located in Kendall Square, Cambridge, MA.
Read more about how the Atinary Lab will showcase the lab of the future, equipped to solve some of the most complex challenges in R&D: full press release